Critical barriers for preeclampsia diagnosis and treatment in low-resource settings: An example from Bolivia.
High altitude
Infant mortality
Maternal mortality
Mobile health technologies
Journal
Pregnancy hypertension
ISSN: 2210-7797
Titre abrégé: Pregnancy Hypertens
Pays: Netherlands
ID NLM: 101552483
Informations de publication
Date de publication:
Apr 2019
Apr 2019
Historique:
received:
20
12
2018
revised:
26
02
2019
accepted:
13
03
2019
entrez:
7
5
2019
pubmed:
6
5
2019
medline:
4
12
2019
Statut:
ppublish
Résumé
The goals of the United Nation's Millennium Summit for reducing maternal mortality have proven difficult to achieve. In Bolivia, where maternal mortality is twice the South American average, improving the diagnosis, treatment and ultimately prevention of preeclampsia is key for achieving targeted reductions. We held a workshop in La Paz, Bolivia to review recent revisions in the diagnosis and treatment of preeclampsia, barriers for their implementation, and means for overcoming them. While physicians are generally aware of current recommendations, substantial barriers exist for their implementation due to geographic factors increasing disease prevalence and limiting health-care access, cultural and economic factors affecting the care provided, and infrastructure deficits impeding diagnosis and treatment. Means for overcoming such barriers include changes in the culture of health care, use of standardized diagnostic protocols, the adoption of low-cost technologies for improving the diagnosis and referral of preeclamptic cases to specialized treatment centers, training programs to foster multidisciplinary team approaches, and efforts to enhance local research capacity. While challenging, the synergistic nature of current barriers for preeclampsia diagnosis and treatment also affords opportunities for making far-reaching improvements in maternal, infant and lifelong health.
Identifiants
pubmed: 31056149
pii: S2210-7789(18)30769-4
doi: 10.1016/j.preghy.2019.03.008
pmc: PMC6502264
mid: NIHMS1527264
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
139-144Subventions
Organisme : NICHD NIH HHS
ID : R01 HD088590
Pays : United States
Organisme : NHLBI NIH HHS
ID : R01 HL138181
Pays : United States
Organisme : FIC NIH HHS
ID : R21 TW010797
Pays : United States
Informations de copyright
Copyright © 2019 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.
Références
Pediatr Res. 2003 Jul;54(1):20-5
pubmed: 12700368
BJOG. 2009 Aug;116(9):1210-7
pubmed: 19459864
Obstet Gynecol. 2010 Aug;116(2 Pt 1):402-14
pubmed: 20664402
Womens Health Issues. 2010 Sep;20(5):304-7
pubmed: 20800765
Obstet Gynecol. 2013 Nov;122(5):1122-31
pubmed: 24150027
BMC Pregnancy Childbirth. 2014 Jan 31;14:56
pubmed: 24484741
Lancet. 2014 Sep 13;384(9947):980-1004
pubmed: 24797575
Nature. 2014 Jun 12;510(7504):202-3
pubmed: 24919906
Blood Press Monit. 2015 Feb;20(1):52-5
pubmed: 25243711
Lancet. 2016 Jan 30;387(10017):462-74
pubmed: 26584737
Comput Inform Nurs. 2016 May;34(5):206-13
pubmed: 26955009
J Appl Physiol (1985). 2017 Nov 1;123(5):1371-1385
pubmed: 28860167
Placenta. 2017 Sep;57:223-224
pubmed: 28864015
Curr Hypertens Rep. 2017 Oct 6;19(10):83
pubmed: 28986756
Pregnancy Hypertens. 2018 Apr;12:183-188
pubmed: 29175171
Reprod Health. 2018 Jan 05;15(1):5
pubmed: 29304812
Hypertension. 2018 Jun;71(6):1185-1192
pubmed: 29686018
Am J Public Health. 1997 Jun;87(6):1003-7
pubmed: 9224184